These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37623322)

  • 1. SARS-CoV-2 ORF8 accessory protein is a virulence factor.
    Bello-Perez M; Hurtado-Tamayo J; Mykytyn AZ; Lamers MM; Requena-Platek R; Schipper D; Muñoz-Santos D; Ripoll-Gómez J; Esteban A; Sánchez-Cordón PJ; Enjuanes L; Haagmans BL; Sola I
    mBio; 2023 Oct; 14(5):e0045123. PubMed ID: 37623322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.
    Wu X; Xia T; Shin WJ; Yu KM; Jung W; Herrmann A; Foo SS; Chen W; Zhang P; Lee JS; Poo H; Comhair SAA; Jehi L; Choi YK; Ensser A; Jung JU
    mBio; 2022 Apr; 13(2):e0040222. PubMed ID: 35343786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    Wang X; Wang W; Wang T; Wang J; Jiang Y; Wang X; Qiu Z; Feng N; Sun W; Li C; Yang S; Xia X; He H; Gao Y
    J Virol; 2023 Mar; 97(3):e0001123. PubMed ID: 36877072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
    Tan Y; Schneider T; Leong M; Aravind L; Zhang D
    mBio; 2020 May; 11(3):. PubMed ID: 32471829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression.
    McGrath ME; Xue Y; Taylor L; Dillen C; Ardanuy J; Gonzalez-Juarbe N; Baracco L; Kim R; Hart R; Assad-Garcia N; Vashee S; Frieman MB
    PLoS Pathog; 2024 May; 20(5):e1011669. PubMed ID: 38781259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
    Zinzula L
    Biochem Biophys Res Commun; 2021 Jan; 538():116-124. PubMed ID: 33685621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice.
    da Silva Santos Y; Gamon THM; de Azevedo MSP; Telezynski BL; de Souza EE; de Oliveira DBL; Dombrowski JG; Rosa-Fernandes L; Palmisano G; de Moura Carvalho LJ; Luvizotto MCR; Wrenger C; Covas DT; Curi R; Marinho CRF; Durigon EL; Epiphanio S
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
    Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD
    Front Immunol; 2021; 12():679482. PubMed ID: 34177923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 29-nucleotide deletion in SARS-CoV: truncated versions of ORF8 are under purifying selection.
    Bykova A; Saura A; Glazko GV; Roche-Lima A; Yurchenko V; Rogozin IB
    BMC Genomics; 2023 Jul; 24(1):387. PubMed ID: 37430204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
    Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation.
    Wu F; Chen X; Ma Y; Wu Y; Li R; Huang Y; Zhang R; Zhou Y; Zhan J; Liu S; Xu W
    Microbiol Spectr; 2023 Aug; 11(4):e0123423. PubMed ID: 37318366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.